Pharma News

Elon Musk’s brain-machine interface company Neuralink has a new job posting for a clinical trial director, a position that could help the company move towards its stated goal of testing its brain...

Nearly 3,000 devices receive approval from the FDA each year, according to Pathogenomix Chairman Chris Risley, but only 75 receive a Breakthrough Device Designation. ...

The United Nations-backed Medicines Patent Pool (MPP) has secured agreements with 27 generics makers in Asia and Africa to supply Merck’s COVID-19 oral antiviral, molnupiravir, in 105 low- and mi...

In a study published in the latest issue of the journal Materials Today Advances, a team of researchers explored the utilities of graphene (GO) and its derivatives in combating the severe acute res...

Patrick Soon-Shiong, South African-born head of biotech firms NantWorks and ImmunityBio, has launched a new manufacturing facility in South Africa with the goal of producing 1 billion COVID-19 vacc...

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company i...

The FDA has granted a fast track designation to CYNK-101 in combination with standard frontline chemotherapy, trastuzumab, and pembrolizumab for patients with advanced HER2-positive gastric or gast...

Antares Pharma, Inc. (NASDAQ: ATRS), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATRS-1902 for adrena...

Celcuity Inc. shares were up 6% to $12.18 after the company said the U.S. Food and Drug Administration has granted Fast Track designation to the Company's lead drug candidate, gedatolisib, for the ...

Lysogene has ended its licensing deal with Sarepta Therapeutics for its LYS-SAF302, an experimental therapy for treating a rare inherited disease of the central nervous system called mucopolysaccha...

The European Medicines Agency’s (EMA) product safety committee has begun reviewing drugs treating an advanced liver disease that contain the active compound terlipressin. ...

The FDA has placed a clinical hold on Denali Therapeutics’ and Takeda Pharmaceutical’s experimental Alzheimer’s drug DNL919.